| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |